Skip to main content
PureTech Health plc logo

PureTech Health plc — Investor Relations & Filings

Ticker · PRTC ISIN · GB00BPVG5C82 LEI · 213800LVPDNO2Z9T9I39 IL Manufacturing
Open in API
Filings indexed 1,319 across all filing types
Latest filing 2025-08-13 Regulatory Filings
Country GB United Kingdom
Listing IL PRTC

About PureTech Health plc

https://puretechhealth.com/

PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.

Recent filings

Filing Released Lang Actions
PRTC's Vedanta Announces VE202 Phase 2 Results
Regulatory Filings Classification · 100% confidence The document is a press release issued via the RNS (Regulatory News Service) platform. It announces clinical trial results for a 'Founded Entity' (Vedanta Biosciences) of the company PureTech Health. Since this is a corporate announcement regarding business operations and clinical trial outcomes rather than a formal financial report, dividend notice, or governance document, it falls under the general regulatory announcement category.
2025-08-13 English
PRTC Launches Celea to Advance Ph3-Ready IPF Drug
Regulatory Filings Classification · 98% confidence The document is a press release issued via the RNS Reach service, announcing the launch of a new subsidiary, 'Celea Therapeutics', by PureTech Health plc. It details the appointment of a new CEO for the subsidiary and provides background on the company's clinical programs. As it is a corporate announcement regarding business development and organizational structure that does not fit into specific financial reporting categories like 10-K or ER, it is classified as a general regulatory announcement.
2025-08-12 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed by Invesco Ltd. regarding PureTech Health PLC. It explicitly details a change in voting rights and share ownership thresholds, which is the standard format for a Major Shareholding Notification (MRQ) in the UK regulatory environment.
2025-08-05 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a 'Total Voting Rights and Share Capital' disclosure, which is a standard regulatory requirement under the FCA's Disclosure Guidance and Transparency Rules (DTR 5.6.1). It provides the total number of voting rights and issued share capital as of a month-end date. While it involves share capital, it is a routine regulatory notification rather than a specific 'Share Issue/Capital Change' (SHA) or 'Transaction in Own Shares' (POS) event, and it fits best under the 'Regulatory Filings' (RNS) category as it is a standard RNS-distributed disclosure.
2025-08-01 English
PRTC’s Seaport Begins Phase 2b Study in MDD
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number : 5104R' and contains contact information referencing 'Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange.' This strongly indicates a regulatory news service announcement. The content details a clinical trial update (dosing the first patient in a Phase 2b study) by a subsidiary (Seaport Therapeutics) of the main company (PureTech Health PLC). This type of material—a press release announcing operational/clinical progress—is typically distributed via RNS. Since it is a general announcement that doesn't fit the specific categories like Earnings Release (ER), Capital Update (CAP), or Director's Dealing (DIRS), the most appropriate classification is the general regulatory filing/announcement category, RNS.
2025-07-17 English
6-K
Regulatory Filings
2025-07-16 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.